The Valley Desk

NCT03763877 · Interventional trial

A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD

Overall registry status Completed

Phase 2

Conditions Nonalcoholic Fatty Liver

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov